QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: dmd.106.013342v1 35/4/590    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meier, Y. Articles by Vavricka, S. R. Search for Related Content PubMed PubMed Citation Articles by Meier, Y. Articles by Vavricka, S. R.

Regional Distribution of Solute Carrier mRNA Expression Along the Human Intestinal Tract

Division of Clinical Pharmacology and Toxicology (Y.M., J.J.E., M.G.I., C.H., G.A.K.-U.), and Division of Gastroenterology and Hepatology (J.D., M.F., S.R.V.), Department of Internal Medicine, University Hospital Zurich, Switzerland

Intestinal absorption of drugs, nutrients, and other compounds is mediated by uptake transporters expressed at the apical enterocyte membrane. These compounds are returned to the intestinal lumen or released into portal circulation by intestinal efflux transporters expressed at apical or basolateral membranes, respectively. One important transporter superfamily, multiple members of which are intestinally expressed, are the solute carriers (SLCs). SLC expression levels may determine the pharmacokinetics of drugs that are substrates of these transporters. In this study we characterize the distribution of 15 human SLC transporter mRNAs in histologically normal biopsies from five regions of the intestine of 10 patients. The mRNA expression levels of CNT1, CNT2, apical sodium-dependent bile acid transporter (ABST), serotonin transporter (SERT), PEPT1, and OCTN2 exhibit marked differences between different regions of the intestine: the first five are predominantly expressed in the small intestine, whereas OCTN2 exhibits strongest expression in the colon. Two transporter mRNAs studied (OCTN1, OATP2B1) are expressed at similar levels in all gut sections. In addition, ENT2 mRNA is present at low levels across the colon, but not in the small intestine. The other six SLC mRNAs studied are not expressed in the intestine. Quantitative knowledge of transporter expression levels in different regions of the human gastrointestinal tract could be useful for designing intestinal delivery strategies for orally administered drugs. Furthermore, changes in transporter expression that occur in pathological states, such as inflammatory bowel disease, can now be defined more precisely by comparison with the expression levels measured in healthy individuals.

This article has been cited by other articles:

				K. A. Wojtal, J. J. Eloranta, P. Hruz, H. Gutmann, J. Drewe, A. Staumann, C. Beglinger, M. Fried, G. A. Kullak-Ublick, and S. R. Vavricka Changes in mRNA Expression Levels of Solute Carrier Transporters in Inflammatory Bowel Disease Patients Drug Metab. Dispos., September 1, 2009; 37(9): 1871 - 1877. [Abstract] [Full Text] [PDF]

				H. Tahara, S. W. Yee, T. J. Urban, S. Hesselson, R. A. Castro, M. Kawamoto, D. Stryke, S. J. Johns, T. E. Ferrin, P.-Y. Kwok, et al. Functional Genetic Variation in the Basal Promoter of the Organic Cation/Carnitine Transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5) J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 262 - 271. [Abstract] [Full Text] [PDF]

				K. Klein, G. A. Kullak-Ublick, M. Wagner, M. Trauner, and J. J. Eloranta Hepatocyte nuclear factor-4{alpha} and bile acids regulate human concentrative nucleoside transporter-1 gene expression Am J Physiol Gastrointest Liver Physiol, April 1, 2009; 296(4): G936 - G947. [Abstract] [Full Text] [PDF]

				S. W. Yee, J. E. Shima, S. Hesselson, L. Nguyen, S. De Val, R. J. LaFond, M. Kawamoto, S. J. Johns, D. Stryke, P.-Y. Kwok, et al. Identification and Characterization of Proximal Promoter Polymorphisms in the Human Concentrative Nucleoside Transporter 2 (SLC28A2) J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 699 - 707. [Abstract] [Full Text] [PDF]

				C. D. Klaassen and H. Lu Xenobiotic Transporters: Ascribing Function from Gene Knockout and Mutation Studies Toxicol. Sci., February 1, 2008; 101(2): 186 - 196. [Abstract] [Full Text] [PDF]

				R. K. Gill, N. Pant, S. Saksena, A. Singla, T. M. Nazir, L. Vohwinkel, J. R. Turner, J. Goldstein, W. A. Alrefai, and P. K. Dudeja Function, expression, and characterization of the serotonin transporter in the native human intestine Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G254 - G262. [Abstract] [Full Text] [PDF]